Applied Immune Technologies Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 51
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4

Applied Immune Technologies General Information

Description

Provider of drugs for treatment of cancer, viral and autoimmune diseases. The company specializes in T-Cell Receptor-Like antibodies for therapeutic and diagnostic applications in a variety of cancer, viral and autoimmune diseases, as well as identification and validation of therapeutic targets.

Contact Information

Website
www.tcrl.co.il
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • Post Box 39
  • Gutwirth Industrial Park, Technion City
  • Haifa 32000
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Applied Immune Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Applied Immune Technologies‘s full profile, request access.

Request a free trial

Applied Immune Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Applied Immune Technologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Applied Immune Technologies‘s full profile, request access.

Request a free trial